Drug recall · January 8, 2020
MYORISAN recall
Why: Unit Dose Mispackaging: Customer complaint that a carton labeled as Myorisan 20 mg Capsules, USP erroneously contained one 10-count blister card of the 40 mg product in addition to two 10-count blister cards of the 20 mg product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
MYORISAN (isotretinoin capsules, USP), 20mg, packaged in 30-count Capsules (3 x 10 Prescription Packs) per box, Rx only, Distributed by: VersaPharm Inc. - An Akorn Company, Lake Forset, IL 60045; NDC 61748-302-13.
- Lots / codes
Lot V20M54A, Exp 01/2021
- Quantity
- 4,206 boxes
- Company
- Akorn, Inc., Lake Forest, IL
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- November 15, 2019 · Voluntary: Firm initiated
- Classified
- January 6, 2020
- Reported
- January 8, 2020
- Ended
- August 9, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Isotretinoin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.